Singapore, December 8, 2009: Babycell, a cord blood banking division of RMS, a leading company in India focused in the delivery of the most advanced cell therapy treatments has organized Continuous Medical Education (CME), a podium to create awareness about the Regenerative Medicines among gynecologists and medical practitioners in Pune (India).

 

Regenerative Medicine is an emerging field of interdisciplinary research with clinical implications focused on repair, replacement or regeneration of cells to salvage impaired organ function. Focusing on the various aspects and applications of stem cells and cord blood banking, Dr. Amita Phadnis, Director, Oyster & Pearl (O&P) Hospital and Dr. Dilip Walke made the presentations.

 

Talking about the importance of stem cell in Pediatrics, Dr. Amita Phadnis, Director, Oyster & Pearl (O&P) Hospital said, "In the future, we are sure to witness a revolution in stem cell research and this sector would surely take great strides for the advancement of stem cell research technology and application."

 

Sharing the in insights on the legal aspects of Cord Blood Banking Dr. Dilip Walke mentioned, "Cord blood banking is a once in a lifetime opportunity and all new parents should utilize cord blood banking if possible."

 

From biological insurance, repository services, autologous and allogenic transplants, assisted devices to system solutions the tremendous and potential of stem cell research can be envisioned by viewing it from three different perspectives - science, unmet medical needs and potential product and services range, said experts at the CME.

 

Mr. Satyen Sanghvi, Chief Scientific Officer, RMS and chief mentor behind the CME said, "Regenerative Medicines is an emerging filed in India and through CME, Babycell is kick starting awareness drive about stem cell therapy and cord blood banking where experts from the industry can share their insights and the benefits to the Indian patients.